BlueRipple Health
Self-advocacy training for coronary artery disease. Walk into every appointment prepared. See the portal

Serum Pharmacokinetics of Nattokinase in Humans Following a Single Oral Daily Dose

Martin P Ero, Chung M Ng, Brian H Lewis · Pilot clinical trial

BlueRipple Assessment

Evidence Strength 35/100 · Limited
Clinical Significance 45/100 · Limited

The original source

Ero MP, Ng CM, Mihailovski T, Harvey NR, Lewis BH. A pilot study on the serum pharmacokinetics of nattokinase in humans following a single, oral, daily dose. Altern Ther Health Med. 2013 May-Jun;19(3):16-9.

19 references Sample size: 11
View original →
NattokinasePharmacokineticsAbsorptionSupplement

← All journal research